| Basics |
Natera, Inc.
Natera Inc is a provider of diagnostic services predominantly in the United States. It offers various tests which detect chromosomal abnormalities, reasons for miscarriages and paternity.
|
| IPO Date: |
July 2, 2015 |
| Sector: |
Healthcare |
| Industry: |
Medical Diagnostics and Research |
| Market Cap: |
$21.46B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.18 | 2.48%
|
| Avg Daily Range (30 D): |
$2.48 | 1.60%
|
| Avg Daily Range (90 D): |
$3.34 | 2.20%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.73M |
| Avg Daily Volume (30 D): |
1.01M |
| Avg Daily Volume (90 D): |
1.31M |
| Trade Size |
| Avg Trade Size (Sh.): |
66 |
| Avg Trade Size (Sh.) (30 D): |
41 |
| Avg Trade Size (Sh.) (90 D): |
45 |
| Institutional Trades |
| Total Inst.Trades: |
6,663 |
| Avg Inst. Trade: |
$4.64M |
| Avg Inst. Trade (30 D): |
$9.72M |
| Avg Inst. Trade (90 D): |
$12.97M |
| Avg Inst. Trade Volume: |
.06M |
| Avg Inst. Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$9.03M |
| Avg Closing Trade (30 D): |
$22.26M |
| Avg Closing Trade (90 D): |
$32.93M |
| Avg Closing Volume: |
124.01K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-1.47
|
$-.5
|
$-.41
|
|
Diluted EPS
|
$-1.47
|
$-.5
|
$-.41
|
|
Revenue
|
$ 1.83B
|
$ 501.83M
|
$ 476.06M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -189.76M
|
$ -66.94M
|
$ -53.77M
|
|
Operating Income / Loss
|
$ -227.16M
|
$ -79.18M
|
$ -64.74M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 159.95M
|
$ 28.18M
|
$ 52.74M
|
|
PE Ratio
|
|
|
|
|
